Cross-Sector entity
Every one of those 1 sits in a single category, pharma. Atai Life Sciences is most often covered alongside Compass Pathways, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Atai Life Sciences appears in 1 tracked Cross-Sector story from March 26, 2026.
1 verified story tracked
Last mentioned: Mar 26, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
Every one of those 1 sits in a single category, pharma. Atai Life Sciences is most often covered alongside Compass Pathways, which appears in 1 of these 1 story. The tracked stories average 2 original sources each. Atai Life Sciences appears in 1 tracked Cross-Sector story from March 26, 2026.
Computed from the 1 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Atai Life Sciences. Shared-story counts are live from our verified record — not editorial picks.
King County Resolution
King County Council officially passes the resolution to decriminalize psychedelic mushrooms county-wide.
WA SB 5263 Passed
Washington Governor signs a bill to create a psilocybin task force and pilot program.
Seattle Decriminalization
Seattle City Council passes a resolution to decriminalize the cultivation and possession of psychedelic plants.
King County has officially passed a resolution to decriminalize the possession and use of psychedelic mushrooms, joining a growing list of Pacific Northwest jurisdictions. This move reflects a significant shift toward viewing psilocybin through a public health lens, potentially paving the way for expanded clinical research and therapeutic access in the region.
